home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

GLP and the ARRIVE Guidelines: Basic Principles of Conducting Lab Animal Studies: Extended Online Course

  September 25, 2019  
CfPA-The Center for Professional Advancement, Online Live
December 5, 2019 from 1:00–4:00 p.m. (ET)

Who Should Attend?
This 3-hour online training course would benefit anyone responsible for the design, conduct, and reporting of preclinical trials, whether animal facilities are in-house or using a CRO. Those who are responsible for managing preclinical budget, authoring regulatory submissions, and ensuring quality system adherence will also find this course valuable.

This course is intended for professionals who work in the following areas:
  • In vivo studies for proof of concept
  • Regulatory Submissions, Quality
  • R&D, Preclinical, Clinical
  • Director, Manager, Scientist

Course Description
Adherence to Good Laboratory Practice for Nonclinical Laboratory Studies (GLP) is critical for ensuring the quality and integrity of study data. Nonclinical laboratory studies (sometimes referred to as preclinical studies) are crucial, and prerequisite for demonstrating the safety and key aspects of performance of products intended for human use. In this course we will discuss the origin of GLP, review the major components of GLP, consider case studies that allow participants to examine how they would handle GLP-related situations if confronted with them in their organization, and determine when non-GLP studies might be appropriate.

This 3-hour online, accredited training will take attendees on a journey from understanding the GLP regulations and the new FDA proposed rules impacting GLP studies, to the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines which allow attendees to design and present studies in a clear, organized, scientifically rigorous way. The objective of this course is to equip attendees conducting nonclinical studies with the knowledge needed to carefully consider all aspects of their nonclinical studies and become effective study planners, taking both scientific and financial factors into consideration.

Can't Make this LIVE Webinar?
Simply select the On Demand option when registering and we will send you the link to view the recorded version.

On Demand available approximately 3 business days after the live offering.
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
   Lucia Mokres, Consultant to the Biotechnology Industry, Doctor of Veterinary Medicine

Dr. Lucia Mokres is a Biotechnology Entrepreneurial Consultant based in the Bay Area, specializing in helping early stage companies with novel technology gain traction and develop an investable technology and business model, and helping later stage companies work through regulatory and clinical challenges. Prior to establishing her consultancy, she was the Chief Medical Officer of EpiBiome, Inc., a precision microbiome engineering company that employs a genomics approach to profiling complex microbial communities, and deploys bacterial viruses to selectively eliminate problematic bacteria without the use of small-molecule antibiotics in humans, animals, and plants. In this role she leveraged her clinical, research, and industry background to provide medical oversight and strategic direction for all clinical development activities, defined regulatory strategy, supported marketing and business development activities, and served as the medical point of contact for external stakeholders. Prior to joining EpiBiome, she served as a Principal Clinical Scientist and medical advisor at Evalve (acquired in 2010 by Abbott Vascular), supporting medical safety and development of the MitraClip, a minimally invasive device used to reduce mitral regurgitation without the need for open heart surgery. Prior to joining Evalve, she served as a Program Specialist at Hantel Technologies, a contract medical device engineering and manufacturing firm, serving as a liaison between clients and internal departments, and managing timelines and budgets for projects ranging from single person startups to Fortune 500 companies. She completed her postdoctoral fellowship at Stanford University School of Medicine in the Department of Pediatrics.

In her spare time, she instructs a Stanford Medical School elective, which provides training for medical students, nurses, physicians and other healthcare professionals in bedside manner, teamwork, leadership, and nonverbal communication skills; serves on the Association for Women in Science STEM to Market Advisory Board; is a member of the AWIS Palo Alto Mentoring Committee; and mentors other early stage companies through the Springboard Enterprises and California Life Sciences Institute advisory programs.

She completed her postdoctoral fellowship at Stanford University School of Medicine in the Department of Pediatrics, and graduated Cum Laude with a Doctorate in Veterinary Medicine from Colorado State University College of Veterinary Medicine and Biomedical Sciences.
Deadline for Abstracts: n/a
Registration: Please click here for registration information.
E-mail: Jmorbit@cfpa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.